Inhibition of double-stranded RNA-induced inducible nitric oxide synthase expression by fraxinellone and sauchinone in murine microglia

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 11, 2009, Pages 1870-1874

  Lee, Chang Seok ^a   Won, Cheolhee ^a   Yoo, Hyouna ^a   Yi, Eun Hee ^a   Cho, Yuri ^a   Maeng, Jung Woo ^a   Sung, Sang Hyun ^b   Ye, Sang Kyu ^a   Chung, Myung Hee ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

c Jun N terminal kinase; Double stranded RNA; Fraxinellone; Inducible nitric oxide synthase; Sauchinone; STAT

Indexed keywords

ANTIINFLAMMATORY AGENT; DOUBLE STRANDED RNA; FRAXINELLONE; INDUCIBLE NITRIC OXIDE SYNTHASE; SAUCHINONE; STAT1 PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; INFLAMMATION; MICROGLIA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; BENZOFURANS; BENZOPYRANS; BLOTTING, WESTERN; DIOXOLES; DNA PRIMERS; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; RNA, DOUBLE-STRANDED; TOLL-LIKE RECEPTOR 3; TRANSCRIPTION, GENETIC;

EID: 70350731120     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1870     Document Type: Article

References (20)

1. Kreutzberg G. W., Trends Neurosci., 19, 312-318 (1996).
2. Town T., Jeng D., Alexopoulou L., Tan J., Flavell R. A., J. Immunol., 176, 3804-3812 (2006).
3. Kong P. J., Lee H. J., Lee S. H., Kim S. Y., Lee S. N., Chun W. J., Kim S. S., Neurosci. Lett., 433, 215-218 (2008).
4. O'Shea J. J., Murray P. J., Immunity, 28, 477-487 (2008).
5. Planas A. M., Gorina R., Chamorro A., Biochem. Soc. Trans., 34, 1267-1270 (2006).
6. Kim H. S., Ye S. K., Cho I. H., Jung J. E., Kim D. H., Choi S., Kim Y. S., Park C. G., Kim T. Y., Lee J. W., Chung M. H., Free Radic. Biol. Med., 41, 1392-1403 (2006).
7. de Prati A. C., Ciampa A. R., Cavalieri E., Zaffini R., Darra E., Menegazzi M., Suzuki H., Mariotto S., Curr. Med. Chem., 12, 1819-1828 (2005).
8. Kleinert H., Schwarz P. M., Förstermann U., Biol. Chem., 384, 1343-1364 (2003).
9. Yoon J. S., Sung S. H., Kim Y. C., J. Nat. Prod., 71, 208-211 (2008).
10. Sung S. H., Kim Y. C., J. Nat. Prod., 63, 1019-1021 (2000).
11. Song H., Kim Y. C., Moon A., Biol. Pharm. Bull., 26, 1428-1430 (2003).
12. Hwang B. Y., Lee J. H., Jung H. S., Kim K. S., Nam J. B., Hong Y. S., Paik S. G., Lee J. J., Planta Med., 69, 1096-1101 (2003).
13. Lee A. K., Sung S. H., Kim Y. C., Kim S. G., Br. J. Pharmacol., 139, 11-20 (2003).
14. Nakamichi K., Saiki M., Kitani H., Kuboyama Y., Morimoto K., Takayama-Ito M., Kurane I., Neurosci. Lett., 13, 222-227 (2007).
15. Mogensen T. H., Paludan S. R., Microbiol. Mol. Biol. Rev., 65, 131-150 (2001).
16. Huang C., Ma R., Sun S., Wei G., Fang Y., Liu R., Li G., J. Neuroimmunol., 204, 118-125 (2008).
17. Chen J. C., Ho F. M., Pei-Dawn Lee Chao., Chen C. P., Jeng K. C., Hsu H. B., Lee S. T., Wen Tung Wu., Lin W. W., Eur. J. Pharmacol., 521, 9-20 (2005).
18. Liu P., Jamaluddin M., Li K., Garofalo R. P., Casola A., Brasier A. R., J. Virol., 81, 1401-1411 (2007).
19. Malmgaard L., J. Interferon Cytokine Res., 24, 439-454 (2004)
20. Peters K. L., Smith H. L., Stark G. R., Sen G. C., Proc. Natl. Acad. Sci. U.S.A., 99, 6322-6327 (2002).